ABCL

AbCellera Biologics Inc.

Healthcare›Biotechnology|NASDAQ Global Select|CA

Price

$3.52

Market Cap

$1.07B

Beta

0.87

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+160.55%

EPS Growth (YoY)+12.50%

Revenue CAGR 3Y-46.31%

P/E Ratio0.0

PEG Ratio—

FCF Yield-16.31%

Debt / Equity0.13

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for ABCL.